Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer
Adoptive cell therapy (ACT) is one of promising immunotherapies for cancer patients by providing a large amount of cancer antigen-specific effector T cells that can be manufactured rapidly by ex vivo gene engineering. To provide antigen-specificity to patients’ autologous T cells in a short-term cul...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2022-12-01
|
| Col·lecció: | OncoImmunology |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.1080/2162402X.2021.2020983 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|